Clinical

Dataset Information

0

Vitamin E in onoxaliplatin-induced neuropathy prevention


ABSTRACT: Intervention 1: in intervention group :vitamin E 400 mg daily. Intervention 2: Control group were observed.;Prevention;in intervention group :vitamin E 400 mg daily;Control group were observed Primary outcome(s): Peripheral neuropathy. Timepoint: before study and then 3 months later. Method of measurement: questionnaire. Study Design: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.

DISEASE(S): Drug-induced Polyneuropathy,Malignant Neoplasm Of Rectosigmoid Junction,Condition 1: Cancer Of Colorectal. Condition 2: Pripheral Neuropathy

PROVIDER: 2485714 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2017-02-09 | GSE86200 | GEO
2008-07-01 | E-MEXP-1327 | biostudies-arrayexpress
| 2620297 | ecrin-mdr-crc
2015-11-02 | E-GEOD-74560 | biostudies-arrayexpress
2015-09-15 | GSE72038 | GEO
2015-09-15 | E-GEOD-72038 | biostudies-arrayexpress
2015-11-16 | GSE74548 | GEO
2014-04-08 | GSE56583 | GEO
| PRJNA76061 | ENA
2014-04-08 | E-GEOD-56583 | biostudies-arrayexpress